silenced in mouse and human B-cell lymphomas Expression of sprouty2 inhibits B-cell proliferation and is epigenetically

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sprouty proteins, masterminds of receptor tyrosine kinase signaling

  2008cited by this paper
• Evidence That Sprouty 2 Is Necessary for Sarcoma Formation by H-Ras Oncogene-transformed Human Fibroblasts*

  2008cited by this paper
• Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas

  2008cited by this paper
• Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

  2008cited by this paper
• Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms

  2007cited by this paper
• Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

  2007cited by this paper
• TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

  2007cited by this paper
• Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

  2007cited by this paper
• Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas

  2007cited by this paper
• Nicotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction.

  2007cited by this paper
• Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis.

  2007cited by this paper
• Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

  2006cited by this paper
• Regulator of epidermal growth factor signaling: Sprouty.

  2006cited by this paper
• Sprouty and cancer: the first terms report.

  2006cited by this paper
• Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.

  2006cited by this paper
• Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.

  2006cited by this paper
• ERK Signaling Is a Molecular Switch Integrating Opposing Inputs from B Cell Receptor and T Cell Cytokines to Control TLR4-Driven Plasma Cell Differentiation1

  2006cited by this paper
• Dual Effects of Sprouty1 on TCR Signaling Depending on the Differentiation State of the T Cell1

  2006cited by this paper
• A negative feedback signaling network underlies oncogene-induced senescence.

  2006cited by this paper
• Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma.

  2006cited by this paper
• Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing FGF signaling.

  2005cited by this paper
• RasGRP1 and RasGRP3 Regulate B Cell Proliferation by Facilitating B Cell Receptor-Ras Signaling1

  2005cited by this paper
• TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.

  2005cited by this paper
• Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer

  2005cited by this paper
• B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation1

  2005cited by this paper
• BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway

  2005cited by this paper
• T Cell Leukemia-1 Modulates TCR Signal Strength and IFN-γ Levels through Phosphatidylinositol 3-Kinase and Protein Kinase C Pathway Activation1

  2005cited by this paper
• Novel role of the Ras cascade in memory B cell response.

  2005cited by this paper
• Modulation of signalling by Sprouty: a developing story

  2004cited by this paper
• Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets

  2004cited by this paper
• The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer

  2004cited by this paper
• Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.

  2003cited by this paper
• Functional analysis of the human Sprouty2 gene promoter.

  2003cited by this paper
• BRAF mutations in non-Hodgkin's lymphoma

  2003cited by this paper
• Split personalities: the agonistic antagonist Sprouty

  2003cited by this paper
• hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.

  2003cited by this paper
• Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination

  2003cited by this paper
• Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Restriction landmark genome scanning.

  2002cited by this paper
• Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma

  2002cited by this paper
• DNA methylation profiling: a new tool for evaluating hematologic malignancies.

  2002cited by this paper
• ERK pathway positively regulates the expression of Sprouty genes.

  2001cited by this paper
• Mammalian Sprouty-1 and -2 Are Membrane-Anchored Phosphoprotein Inhibitors of Growth Factor Signaling in Endothelial Cells

  2001cited by this paper
• TCL1 Oncogene Expression in B Cell Subsets from Lymphoid Hyperplasia and Distinct Classes of B Cell Lymphoma

  2001cited by this paper
• The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.

  2001cited by this paper
• Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen1

  2001cited by this paper
• Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

  2000cited by this paper
• TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

  1999cited by this paper
• sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways.

  1998cited by this paper
• Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype.

  1996cited by this paper
• Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.

  1994cited by this paper
• Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

  1994cited by this paper
• Multiple motifs regulate the B-cell-specific promoter of the B29 gene.

  1993cited by this paper
• Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Analysis of RAS oncogene mutations in human lymphoid malignancies.

  1988cited by this paper
• Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts

  1986cited by this paper

• No citing papers are available for this paper.